SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-020827
Filing Date
2020-11-09
Accepted
2020-11-09 16:31:18
Documents
92
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1734905
2 ex10-1.htm EX-10.1 183938
3 ex31-1.htm EX-31.1 18874
4 ex31-2.htm EX-31.2 18980
5 ex32-1.htm EX-32.1 8303
  Complete submission text file 0001493152-20-020827.txt   8992307

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE hrow-20200930.xsd EX-101.SCH 63236
7 XBRL CALCULATION FILE hrow-20200930_cal.xml EX-101.CAL 85345
8 XBRL DEFINITION FILE hrow-20200930_def.xml EX-101.DEF 298452
9 XBRL LABEL FILE hrow-20200930_lab.xml EX-101.LAB 515213
10 XBRL PRESENTATION FILE hrow-20200930_pre.xml EX-101.PRE 407645
11 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1688226
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW HEALTH, INC. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35814 | Film No.: 201298160
SIC: 2834 Pharmaceutical Preparations